| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.1M | +86.4% |
| SG&A Expense | $7.8M | +114.4% |
| Operating Income | -$15.4M | -46.1% |
| Income Tax | $0 | — |
| Net Income | -$14.8M | -41.9% |
| EPS (Basic) | -$0.93 | +74.8% |
| EPS (Diluted) | -$0.93 | +74.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.5M | -28.5% |
| Current Assets | $37.9M | -26.1% |
| Total Assets | $38.0M | -26.0% |
| Current Liabilities | $3.2M | +5.7% |
| Total Liabilities | $3.2M | +5.7% |
| Stockholders' Equity | $34.8M | -28.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.5M | -54.0% |
| Capital Expenditures | $37K | — |
| Investing Cash Flow | -$537K | -114.7% |
| Financing Cash Flow | -$102K | -100.2% |
| Free Cash Flow | -$13.6M | -54.4% |